//
The Regional Government has redistributed budgetary burdens for the acquisition of Eftrenonacog Alfa, ensuring treatment for patients at SESARAM.
The Regional Secretariat for Health and Civil Protection has published Ordinance no. 179/2026, which proceeds with the redistribution and amendment of budgetary burdens for the acquisition of anti-hemorrhagic drugs, specifically the medication Eftrenonacog Alfa, intended for the Health Service of the Autonomous Region of Madeira, EPERAM (SESARAM).
The global base price for the acquisition is 706,212.15 €, plus VAT at a rate of 6%. The financial burden has been fully allocated to the 2026 fiscal year, ensuring the continuity of specialized healthcare required for users of the regional service.
The new ordinance establishes the values and payment conditions of the supplement for doctors exercising health authority functions in the Region.
The Health Administration Institute, IP-RAM, has been authorized to regularize payments to three mental health institutions effective January 1, 2025.
The Regional Government has awarded public commendations to Dr. João Manuel Rodrigues Silva and Dr. Miguel Dinis Jardim Homem Costa for their contributions to healthcare in Madeira.